Microglial proliferation attenuates sickness responses in adult mice during endotoxin-induced inflammation

Katsuhiro Torii1, Shohei Takagi1, Ryoichi Yoshimura1

  • 1Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan.

Journal of Neuroimmunology
|February 22, 2022
PubMed

Insights

A transient increase in brain microglia benefits mice during endotoxin-induced inflammation. Inhibiting this microglial proliferation prolonged sickness responses, indicating a protective role.

Area of Science:

  • Neuroscience
  • Immunology
  • Neuroinflammation

Background:

  • Peripheral administration of lipopolysaccharide (LPS) induces microglial proliferation in specific brain regions.
  • The functional significance of this increased microglial population during inflammation is not fully understood.

Purpose of the Study:

  • To investigate the functional significance of microglial proliferation during inflammation induced by various agents.
  • To determine the role of LPS-induced microglial proliferation in sickness responses.

Main Methods:

  • Induced inflammation using zymosan, prostaglandin E2, and LPS in mice.
  • Inhibited LPS-induced microglial proliferation using continuous intracerebroventricular (i.c.v.) infusion of cytosine arabinoside (AraC).
  • Monitored body weight, food and water intake, locomotor activity, and core body temperature.

Main Results:

  • Microglial proliferation was observed in response to zymosan, prostaglandin E2, and LPS.
  • Inhibition of LPS-induced microglial proliferation with AraC led to sustained decreases in body weight and intake.
  • AraC infusion prolonged LPS-induced sickness behaviors, including reduced activity and body temperature.

Conclusions:

  • A transient increase in the brain's microglial population is beneficial during endotoxin-induced inflammation.
  • Microglial proliferation plays a protective role by attenuating sickness responses in the mouse brain.

Related Concept Videos